Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberculosis notifications in Australia, 2000.

Ming Lin, Jenean Spencer, Paul Roche

    Communicable Diseases Intelligence Quarterly Report
    |September 11, 2002
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A practical alternative to live cell-based assay for AQP4 and MOG antibody detection.

    EBioMedicine·2026
    Same author

    Intravenous human umbilical cord-derived mesenchymal stem cell transplantation for ischemic stroke (MERIT): A phase 1 trial.

    Cell reports. Medicine·2026
    Same author

    Study on the Mechanism of Berberine Reversing MRSA Resistance to β-Lactam Antibiotics by Inhibiting blaZ Expression.

    International microbiology : the official journal of the Spanish Society for Microbiology·2026
    Same author

    Effect of bucladesine calcium combined with metoprolol on heart rate variability and cardiac function prognosis in heart failure patients with chronic arrhythmias.

    Frontiers in cardiovascular medicine·2026
    Same author

    Acylhydrazone-Linked Covalent Organic Frameworks.

    Journal of the American Chemical Society·2026
    Same author

    Robot-assisted gait training alleviates the symptoms of acute ischemic stroke via regulating gut microbiota composition and function.

    Frontiers in cellular and infection microbiology·2026
    Same journal

    National Notifiable Diseases Surveillance System, 1 October to 31 December 2017.

    Communicable diseases intelligence quarterly report·2018
    Same journal

    National Notifiable Diseases Surveillance System, 1 July to 30 September 2017.

    Communicable diseases intelligence quarterly report·2018
    Same journal

    National Notifiable Diseases Surveillance System, 1 April to 30 June 2017.

    Communicable diseases intelligence quarterly report·2018
    Same journal

    OzFoodNet quarterly report, 1 July to 30 September 2015.

    Communicable diseases intelligence quarterly report·2018
    Same journal

    OzFoodNet quarterly report, 1 April to 30 June 2015.

    Communicable diseases intelligence quarterly report·2018
    Same journal

    The Australian Sentinel Practices Research Network, 1 January to 31 March 2017.

    Communicable diseases intelligence quarterly report·2018
    See all related articles

    Australia maintains a low tuberculosis (TB) incidence, with stable rates since 1991. However, TB disproportionately affects overseas-born individuals and Indigenous Australians.

    Area of Science:

    • Public Health
    • Epidemiology
    • Infectious Diseases

    Background:

    • Australia exhibits one of the world's lowest tuberculosis (TB) incidence rates.
    • The annual TB incidence has remained stable at 5-6 cases per 100,000 population since 1991.

    Purpose of the Study:

    • To analyze the incidence and demographic distribution of tuberculosis (TB) in Australia in 2000.
    • To identify high-risk populations for TB in Australia.

    Main Methods:

    • Retrospective analysis of national TB notification data for the year 2000.
    • Calculation of incidence rates per 100,000 population for different demographic groups.

    Main Results:

    • In 2000, Australia recorded 1,060 TB notifications (5.2/100,000 for new cases, 0.3/100,000 for relapsed cases).

    Related Experiment Videos

  • The highest TB incidence was observed in overseas-born (18.0/100,000) and Indigenous Australians (15.3/100,000).
  • The non-Indigenous Australian-born population had a low incidence rate of 1.2/100,000.

    • Conclusions:

    • Tuberculosis incidence in Australia remains low overall.
    • Significant disparities in TB incidence exist, with overseas-born and Indigenous Australians facing higher risks.
    • Targeted public health interventions are crucial for high-risk groups in Australia.